Scotts Miracle-Gro (SMG) Financials

$60.08 +0.69 (+1.17%)

Closing price 03:59 PM Eastern

Extended Trading

$59.63 -0.45 (-0.75%)

As of 05:38 PM Eastern

Annual Income Statements for Scotts Miracle-Gro

This table shows Scotts Miracle-Gro's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	160	315	218	64	461	387	513	-438	-380	-35	145
Consolidated Net Income / (Loss)	159	315	219	64	460	389	513	-438	-380	-35	145
Net Income / (Loss) Continuing Operations	129	246	198	128	437	387	517	-438	-380	-35	145
Total Pre-Tax Income	205	384	315	116	582	511	677	-558	-453	-24	222
Total Operating Income	254	448	433	199	410	585	723	-434	-174	209	359
Total Gross Profit	811	900	973	865	1,020	1,347	1,469	873	657	851	1,044
Total Revenue	2,371	2,506	2,642	2,663	3,156	4,132	4,925	3,924	3,551	3,553	3,413
Operating Revenue	2,371	2,506	2,642	2,663	3,156	4,132	4,925	3,924	3,551	3,553	3,413
Total Cost of Revenue	1,560	1,606	1,670	1,799	2,136	2,785	3,456	3,051	2,894	2,702	2,369
Operating Cost of Revenue	1,557	1,600	1,670	1,778	2,131	2,769	3,431	2,891	2,708	2,619	2,349
Other Cost of Revenue	3.00	5.90	0.00	21	5.90	16	25	160	186	84	20
Total Operating Expenses	557	453	539	666	610	762	746	1,307	832	642	686
Selling, General & Admin Expense	489	518	551	540	601	758	744	613	551	559	603
Other Operating Expenses / (Income)	-2.20	-14	-17	-6.70	1.30	3.20	-1.80	0.80	-0.10	20	19
Restructuring Charge	70	-52	4.90	132	7.40	0.80	4.30	693	281	63	63
Total Other Income / (Expense), net	-49	-64	-119	-83	172	-75	-46	-124	-279	-232	-137
Interest Expense	49	72	76	86	102	95	79	118	178	159	129
Interest & Investment Income	0.00	7.80	-29	4.90	3.30	0.00	14	-13	-101	-68	-2.80
Other Income / (Expense), net	0.00	0.00	-13	-1.70	271	20	19	6.90	0.30	-5.50	-5.30
Income Tax Expense	76	138	117	-12	145	124	160	-121	-73	11	77
Basic Earnings per Share	$2.62	$5.16	$3.68	$1.13	$8.30	$6.96	$9.20	($7.88)	($6.79)	($0.61)	$2.52
Weighted Average Basic Shares Outstanding	61.10M	61.10M	59.40M	56.20M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M	58.00M
Diluted Earnings per Share	$2.57	$5.09	$3.63	$1.12	$8.18	$6.81	$8.96	($7.88)	($6.79)	($0.61)	$2.47
Weighted Average Diluted Shares Outstanding	61.10M	61.10M	59.40M	56.20M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M	58.00M
Weighted Average Basic & Diluted Shares Outstanding	61.10M	61.10M	59.40M	56.20M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M	58.00M
Cash Dividends to Common per Share	$1.82	$1.91	$2.03	$2.14	$2.23	$7.36	$2.52	$2.64	$2.64	$2.64	$2.64

This table shows Scotts Miracle-Gro's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/30/2024	12/28/2024	3/29/2025	6/28/2025	9/30/2025	12/27/2025
Net Income / (Loss) Attributable to Common Shareholders	44	-469	-81	158	132	-244	-70	218	149	-152	-125
Consolidated Net Income / (Loss)	44	-469	-81	158	132	-244	-70	218	149	-152	-125
Net Income / (Loss) Continuing Operations	44	-469	-81	158	132	-244	-66	218	149	-152	-48
Total Pre-Tax Income	52	-561	-114	220	183	-312	-91	301	207	-191	-63
Total Operating Income	77	-416	-47	272	200	-216	-46	345	215	-150	-22
Total Gross Profit	206	-57	62	464	354	-30	89	548	378	24	89
Total Revenue	1,119	375	410	1,525	1,202	415	367	1,421	1,188	387	354
Operating Revenue	1,119	375	410	1,525	1,202	415	367	1,421	1,188	387	354
Total Cost of Revenue	913	432	348	1,062	848	444	278	873	810	364	266
Operating Cost of Revenue	880	408	354	987	851	427	277	866	806	360	264
Other Cost of Revenue	33	24	-5.80	75	-2.50	17	1.40	7.30	3.70	4.20	1.30
Total Operating Expenses	129	359	110	192	154	187	134	203	163	174	111
Selling, General & Admin Expense	129	108	115	179	148	118	114	188	153	137	106
Other Operating Expenses / (Income)	-1.60	2.60	1.80	11	6.90	0.40	4.30	4.20	7.20	2.90	2.70
Restructuring Charge	1.70	249	-7.10	2.10	-0.80	69	17	11	2.40	34	1.80
Total Other Income / (Expense), net	-25	-145	-67	-52	-17	-96	-45	-44	-7.70	-41	-42
Interest Expense	47	40	43	44	39	33	34	37	32	27	27
Interest & Investment Income	22	-105	-23	-7.00	23	-62	-9.90	-5.90	25	-12	-13
Other Income / (Expense), net	-0.40	-0.10	-1.60	-1.20	-1.30	-1.40	-1.30	-1.30	-1.20	-1.50	-1.20
Income Tax Expense	8.30	-92	-34	62	51	-68	-25	83	58	-39	-16
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-3.40	-	-	-	-77
Basic Earnings per Share	$0.78	($8.35)	($1.42)	$2.77	$2.33	($4.29)	($1.21)	$3.78	$2.58	($2.63)	($2.16)
Weighted Average Basic Shares Outstanding	56.20M	56.55M	56.70M	56.80M	56.80M	57.41M	57.30M	57.60M	57.70M	58.00M	57.90M
Diluted Earnings per Share	$0.77	($8.33)	($1.42)	$2.74	$2.28	($4.21)	($1.21)	$3.72	$2.54	($2.58)	($2.16)
Weighted Average Diluted Shares Outstanding	56.60M	56.55M	56.70M	57.40M	58M	57.41M	57.30M	58.40M	58.60M	58.00M	57.90M
Weighted Average Basic & Diluted Shares Outstanding	56.16M	56.55M	56.69M	56.80M	56.82M	57.41M	57.47M	57.72M	57.74M	58.00M	58.04M
Cash Dividends to Common per Share	$0.66	-	$0.66	$0.66	$0.66	-	$0.66	$0.66	$0.66	-	$0.66

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Change in Cash & Equivalents	-18	-21	70	-87	-15	-2.20	228	-157	-55	40	-35
Net Cash From Operating Activities	247	244	363	343	227	558	272	-129	531	668	371
Net Cash From Continuing Operating Activities	247	244	363	343	227	558	272	-129	531	668	371
Net Income / (Loss) Continuing Operations	159	315	219	64	460	389	513	-438	-380	-35	145
Consolidated Net Income / (Loss)	159	315	219	64	460	389	513	-438	-380	-35	145
Depreciation Expense	51	54	55	53	56	62	63	68	67	65	63
Amortization Expense	18	20	25	30	33	33	31	37	25	16	12
Non-Cash Adjustments To Reconcile Net Income	18	-114	24	169	-224	73	38	714	459	233	111
Changes in Operating Assets and Liabilities, net	1.70	-30	40	27	-99	1.70	-374	-511	360	389	40
Net Cash From Investing Activities	-536	-134	22	-581	255	47	-539	-283	-66	-100	-112
Net Cash From Continuing Investing Activities	-536	-134	22	-581	255	47	-539	-283	-66	-100	-112
Purchase of Property, Plant & Equipment	-62	-58	-70	-68	-42	-63	-107	-114	-93	-84	-97
Acquisitions	-480	-183	-122	-528	-6.60	0.00	-128	-237	0.00	-21	-2.50
Other Investing Activities, net	0.00	-90	-30	11	7.00	-2.90	-8.70	29	27	5.00	-12
Net Cash From Financing Activities	279	-129	-317	151	-497	-607	494	255	-520	-528	-294
Net Cash From Continuing Financing Activities	279	-129	-317	151	-497	-607	494	255	-520	-528	-294
Repayment of Debt	-1,460	-2,364	-1,651	-2,328	-1,447	-1,833	-1,375	-2,941	-1,700	-1,024	-836
Repurchase of Common Equity	-15	-137	-255	-398	-3.10	-53	-129	-258	-9.30	-5.10	-18
Payment of Dividends	-111	-117	-128	-120	-125	-411	-143	-166	-149	-151	-154
Issuance of Debt	1,836	2,469	1,449	2,987	1,056	1,673	2,143	3,617	1,336	649	703
Other Financing Activities, net	29	21	269	11	21	18	-2.30	3.30	2.30	3.80	12
Other Net Changes in Cash	-	-	1.60	-	-	0.00	0.60	-	-0.10	0.50	-0.20

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/30/2024	12/28/2024	3/29/2025	6/28/2025	9/30/2025	12/27/2025
Net Change in Cash & Equivalents	2.40	4.50	-22	55	215	-208	-62	7.10	34	-15	-25
Net Cash From Operating Activities	563	535	-343	304	588	119	-445	188	454	174	-370
Net Cash From Continuing Operating Activities	563	535	-343	304	588	119	-445	188	454	174	-370
Net Income / (Loss) Continuing Operations	44	-468	-81	158	132	-244	-70	218	149	-152	-125
Consolidated Net Income / (Loss)	44	-468	-81	158	132	-244	-70	218	149	-152	-125
Depreciation Expense	16	18	16	16	17	16	16	16	16	16	16
Amortization Expense	6.70	4.40	4.00	3.90	3.90	3.90	3.10	3.20	3.10	2.90	2.80
Non-Cash Adjustments To Reconcile Net Income	-22	359	39	41	-1.10	154	38	32	-7.80	49	126
Changes in Operating Assets and Liabilities, net	519	622	-322	86	437	188	-433	-80	295	258	-390
Net Cash From Investing Activities	-24	-21	-53	-18	-8.90	-20	-23	-11	-25	-52	-22
Net Cash From Continuing Investing Activities	-24	-21	-53	-18	-8.90	-20	-23	-11	-25	-52	-22
Purchase of Property, Plant & Equipment	-22	-19	-38	-16	-13	-17	-29	-8.30	-17	-43	-20
Other Investing Activities, net	-2.00	32	6.10	-1.60	4.30	-6.20	6.00	-3.10	-8.40	-6.70	-1.80
Net Cash From Financing Activities	-536	-509	374	-231	-364	-307	408	-170	-396	-136	367
Net Cash From Continuing Financing Activities	-536	-509	374	-231	-364	-307	408	-170	-396	-136	367
Repayment of Debt	-600	-512	-31	-266	-456	-271	-63	-254	-413	-106	-733
Repurchase of Common Equity	-2.90	-	-3.10	-1.80	-0.10	-0.10	-16	-2.70	-0.10	-	-8.30
Payment of Dividends	-37	-37	-37	-39	-38	-38	-39	-39	-38	-38	-38
Issuance of Debt	103	40	445	74	129	-	525	117	54	7.10	1,146
Other Financing Activities, net	0.50	0.60	0.50	1.20	0.70	1.40	0.70	9.30	1.20	0.70	0.70
Effect of Exchange Rate Changes	0.10	-	-	-0.20	-0.40	-	-	0.20	-	-	0.10

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Total Assets	2,527	2,756	2,747	3,055	3,029	3,381	4,800	4,297	3,414	2,872	2,742
Total Current Assets	1,119	1,033	882	886	1,042	1,217	2,024	1,982	1,398	980	940
Cash & Equivalents	71	29	121	34	19	17	244	87	32	72	33
Accounts Receivable	158	127	198	226	224	475	483	379	304	177	161
Inventories, net	396	395	408	481	540	622	1,127	1,344	880	588	543
Prepaid Expenses	121	52	67	60	174	81	170	173	181	145	119
Other Current Nonoperating Assets	220	256	-	-	-	-	-	-	-	-	85
Plant, Property, & Equipment, net	444	445	468	531	546	0.00	622	606	610	610	608
Total Noncurrent Assets	964	1,278	1,398	1,638	1,441	2,164	2,154	1,709	1,406	1,282	1,194
Long-Term Investments	0.00	101	31	36	-	0.00	207	194	92	45	54
Goodwill	284	372	442	543	539	544	605	254	244	244	244
Intangible Assets	655	690	749	857	708	679	710	580	437	419	352
Other Noncurrent Operating Assets	25	115	176	202	195	941	632	681	633	574	453
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	92
Total Liabilities & Shareholders' Equity	2,527	2,756	2,747	3,055	3,029	3,381	4,800	4,297	3,414	2,872	2,742
Total Liabilities	1,894	2,022	2,085	2,695	2,306	2,678	3,787	4,149	3,681	3,263	3,100
Total Current Liabilities	619	707	545	613	621	950	1,140	964	774	750	740
Short-Term Debt	133	185	143	133	128	66	58	144	52	53	57
Accounts Payable	193	131	153	151	214	391	609	423	271	255	221
Other Current Liabilities	251	178	248	330	278	493	473	397	450	443	437
Other Current Nonoperating Liabilities	42	213	-	-	-	-	-	-	-	-	24
Total Noncurrent Liabilities	1,276	1,314	1,541	2,082	1,685	1,727	2,646	3,185	2,907	2,512	2,360
Long-Term Debt	1,025	1,031	1,258	1,884	1,524	1,455	2,237	2,826	2,557	2,174	2,049
Other Noncurrent Operating Liabilities	251	284	283	198	162	272	410	359	350	338	301
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	-	9.60
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	633	734	662	360	723	703	1,013	148	-267	-391	-358
Total Preferred & Common Equity	621	715	649	355	719	697	1,013	148	-267	-391	-358
Total Common Equity	621	715	649	355	719	697	1,013	148	-267	-391	-358
Common Stock	400	402	408	420	442	483	477	364	353	362	352
Retained Earnings	684	882	978	920	1,275	1,236	1,605	1,020	491	304	295
Treasury Stock	-357	-451	-668	-940	-904	-922	-1,002	-1,092	-999	-949	-894
Accumulated Other Comprehensive Income / (Loss)	-107	-117	-69	-46	-94	-99	-66	-145	-113	-107	-110

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	7/2/2022	12/31/2022	4/1/2023	7/1/2023	12/30/2023	3/30/2024	6/29/2024	12/28/2024	3/29/2025	6/28/2025	12/27/2025
Total Assets	4,994	4,534	4,988	4,454	3,716	3,924	3,489	3,170	3,537	3,091	3,034
Total Current Assets	2,589	2,299	2,842	2,251	1,681	1,935	1,538	1,285	1,729	1,283	1,257
Cash & Equivalents	28	26	25	27	10	65	280	5.70	17	51	8.30
Accounts Receivable	953	490	1,458	1,160	288	877	505	173	799	574	194
Inventories, net	1,408	1,526	1,128	885	1,170	824	607	845	773	544	847
Prepaid Expenses	201	258	232	179	214	169	147	131	139	114	147
Other Current Nonoperating Assets	-	-	-	-	-	-	-	131	-	-	61
Plant, Property, & Equipment, net	625	593	589	590	610	608	599	574	603	609	617
Total Noncurrent Assets	1,780	1,642	1,557	1,613	1,424	1,381	1,352	1,311	1,206	1,198	1,160
Long-Term Investments	208	182	174	197	91	84	107	46	41	66	41
Goodwill	255	254	254	255	244	244	244	244	244	244	244
Intangible Assets	627	576	566	560	433	429	425	354	412	410	351
Other Noncurrent Operating Assets	690	630	563	602	656	624	576	558	509	479	524
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	108	-	-	0.00
Total Liabilities & Shareholders' Equity	4,994	4,534	4,988	4,454	3,716	3,924	3,489	3,170	3,537	3,091	3,034
Total Liabilities	4,576	4,475	4,851	4,320	4,102	4,175	3,636	3,650	3,827	3,262	3,535
Total Current Liabilities	1,072	932	1,373	1,329	764	1,060	854	684	1,013	799	932
Short-Term Debt	322	217	435	451	55	58	53	55	55	52	278
Accounts Payable	291	367	416	366	333	440	317	284	396	262	284
Other Current Liabilities	459	348	522	513	377	562	485	296	562	485	339
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	49	-	-	32
Total Noncurrent Liabilities	3,504	3,543	3,478	2,991	3,337	3,115	2,781	2,966	2,814	2,463	2,602
Long-Term Debt	3,156	3,190	3,138	2,629	2,969	2,761	2,436	2,637	2,493	2,136	2,250
Other Noncurrent Operating Liabilities	348	353	340	362	368	354	345	324	321	327	352
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	5.10	-	-	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	418	60	138	135	-385	-251	-146	-480	-290	-171	-501
Total Preferred & Common Equity	418	60	138	135	-385	-251	-146	-480	-290	-171	-501
Total Common Equity	418	60	138	135	-385	-251	-146	-480	-290	-171	-501
Common Stock	362	368	374	351	350	354	361	349	343	347	347
Retained Earnings	1,277	918	990	997	372	492	586	196	374	485	131
Treasury Stock	-1,096	-1,057	-1,040	-1,032	-986	-978	-976	-920	-898	-896	-873
Accumulated Other Comprehensive Income / (Loss)	-125	-169	-187	-181	-122	-119	-117	-105	-109	-108	-106

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.04%	5.70%	5.42%	0.81%	18.50%	30.91%	19.20%	-20.32%	-9.50%	0.04%	-3.93%
EBITDA Growth	-7.27%	61.43%	-4.03%	-43.89%	174.20%	-9.02%	19.34%	-138.53%	74.65%	447.92%	50.86%
EBIT Growth	-10.54%	76.36%	-6.17%	-53.05%	244.88%	-11.00%	22.52%	-157.59%	59.24%	216.77%	73.78%
NOPAT Growth	-12.88%	80.17%	-4.93%	-19.63%	40.21%	44.18%	24.57%	-155.00%	59.82%	219.72%	60.69%
Net Income Growth	-4.51%	98.36%	-30.50%	-70.89%	622.45%	-15.56%	32.12%	-185.22%	13.12%	90.82%	516.05%
EPS Growth	-3.02%	98.05%	-28.68%	-69.15%	630.36%	-16.75%	31.57%	-187.95%	13.83%	91.02%	504.92%
Operating Cash Flow Growth	2.49%	-1.17%	48.85%	-5.70%	-33.78%	146.03%	-51.34%	-147.51%	511.63%	25.71%	-44.37%
Free Cash Flow Firm Growth	-265.76%	142.28%	176.12%	-226.11%	246.80%	129.71%	-116.32%	-194.93%	274.54%	29.87%	-54.20%
Invested Capital Growth	22.06%	15.36%	7.53%	20.66%	2.17%	-6.29%	29.39%	-0.67%	-21.81%	-22.50%	-3.53%
Revenue Q/Q Growth	-8.47%	4.18%	13.02%	2.20%	2.06%	10.50%	-3.00%	-5.86%	-3.24%	1.14%	-0.80%
EBITDA Q/Q Growth	-4.86%	4.64%	0.46%	-26.83%	13.75%	12.41%	-6.72%	-133.43%	-170.10%	225.20%	17.70%
EBIT Q/Q Growth	-6.83%	5.27%	0.29%	-34.79%	15.90%	13.91%	-7.29%	-77.59%	-988.27%	4,319.57%	22.93%
NOPAT Q/Q Growth	-9.00%	6.45%	1.11%	-28.35%	31.46%	12.09%	-6.12%	-75.57%	-1,085.31%	2,272.73%	51.31%
Net Income Q/Q Growth	-5.37%	-0.73%	-2.89%	-64.05%	23.91%	19.09%	-9.21%	-64.91%	-188.61%	86.55%	173.45%
EPS Q/Q Growth	-4.10%	-1.17%	-3.46%	-64.44%	23.19%	19.26%	-9.22%	-63.83%	-186.50%	87.10%	194.05%
Operating Cash Flow Q/Q Growth	6.98%	25.90%	-0.36%	27.70%	-15.44%	60.81%	-11.97%	35.82%	-2.80%	-38.44%	17.61%
Free Cash Flow Firm Q/Q Growth	-208.63%	112.76%	-53.24%	43.67%	-12.89%	43.22%	-140.04%	64.74%	-27.09%	-37.96%	39.93%
Invested Capital Q/Q Growth	2.54%	-17.99%	-10.67%	-16.36%	-12.60%	-17.56%	-5.57%	-22.46%	-25.81%	-12.11%	-12.72%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.20%	35.92%	36.81%	32.46%	32.31%	32.60%	29.83%	22.24%	18.51%	23.94%	30.59%
EBITDA Margin	13.61%	20.79%	18.93%	10.54%	24.38%	16.94%	16.96%	-8.20%	-2.30%	7.99%	12.55%
Operating Margin	10.70%	17.86%	16.40%	7.47%	12.98%	14.16%	14.68%	-11.06%	-4.91%	5.88%	10.51%
EBIT Margin	10.70%	17.86%	15.90%	7.40%	21.55%	14.65%	15.06%	-10.88%	-4.90%	5.72%	10.35%
Profit (Net Income) Margin	6.69%	12.56%	8.28%	2.39%	14.58%	9.41%	10.42%	-11.15%	-10.70%	-0.98%	4.25%
Tax Burden Percent	77.41%	82.04%	69.48%	55.06%	79.13%	76.11%	75.82%	78.39%	83.85%	147.88%	65.49%
Interest Burden Percent	80.77%	85.72%	74.98%	58.67%	85.52%	84.35%	91.30%	130.67%	260.37%	-11.61%	62.75%
Effective Tax Rate	37.22%	35.86%	37.03%	-10.29%	24.91%	24.23%	23.60%	0.00%	0.00%	0.00%	34.51%
Return on Invested Capital (ROIC)	11.37%	17.30%	14.80%	10.40%	13.19%	19.43%	21.81%	-10.67%	-4.83%	7.42%	13.90%
ROIC Less NNEP Spread (ROIC-NNEP)	11.29%	20.15%	10.08%	0.66%	21.72%	15.94%	19.49%	-16.57%	-14.80%	-0.46%	9.56%
Return on Net Nonoperating Assets (RNNOA)	15.07%	28.74%	16.55%	2.07%	71.81%	35.07%	38.02%	-64.70%	640.45%	3.19%	-52.72%
Return on Equity (ROE)	26.44%	46.04%	31.35%	12.47%	85.00%	54.50%	59.83%	-75.37%	635.62%	10.61%	-38.82%
Cash Return on Invested Capital (CROIC)	-8.50%	3.04%	7.54%	-8.32%	11.05%	25.93%	-3.81%	-10.00%	19.66%	32.78%	17.50%
Operating Return on Assets (OROA)	11.07%	16.94%	15.27%	6.80%	22.36%	18.89%	18.13%	-9.39%	-4.52%	6.47%	12.59%
Return on Assets (ROA)	6.92%	11.92%	7.95%	2.20%	15.13%	12.13%	12.55%	-9.62%	-9.86%	-1.11%	5.17%
Return on Common Equity (ROCE)	25.87%	44.98%	30.63%	12.26%	84.26%	54.11%	59.63%	-75.37%	635.62%	10.61%	-38.82%
Return on Equity Simple (ROE_SIMPLE)	25.57%	44.02%	33.72%	17.96%	64.03%	55.74%	50.67%	-296.21%	142.20%	8.94%	0.00%
Net Operating Profit after Tax (NOPAT)	159	287	273	219	308	443	552	-304	-122	146	235
NOPAT Margin	6.72%	11.46%	10.33%	8.24%	9.75%	10.73%	11.22%	-7.74%	-3.44%	4.11%	6.88%
Net Nonoperating Expense Percent (NNEP)	0.08%	-2.84%	4.72%	9.74%	-8.53%	3.49%	2.33%	5.90%	9.97%	7.88%	4.35%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	13.43%
Cost of Revenue to Revenue	65.80%	64.08%	63.19%	67.54%	67.69%	67.40%	70.17%	77.76%	81.49%	76.06%	69.41%
SG&A Expenses to Revenue	20.61%	20.67%	20.85%	20.28%	19.05%	18.34%	15.10%	15.62%	15.52%	15.73%	17.68%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.49%	18.06%	20.41%	24.99%	19.33%	18.44%	15.15%	33.30%	23.42%	18.06%	20.09%
Earnings before Interest and Taxes (EBIT)	254	448	420	197	680	605	742	-427	-174	203	353
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	323	521	500	281	769	700	835	-322	-82	284	428
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.62	5.58	7.09	10.20	6.69	10.91	7.28	14.59	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.21	1.59	1.74	1.36	1.52	1.84	1.50	0.55	0.78	1.37	0.95
Price to Earnings (P/E)	17.95	12.66	21.06	56.78	10.43	19.63	14.40	0.00	0.00	0.00	22.36
Dividend Yield	3.89%	2.90%	2.58%	3.28%	2.57%	1.73%	1.91%	6.79%	5.38%	3.07%	4.69%
Earnings Yield	5.57%	7.90%	4.75%	1.76%	9.58%	5.10%	6.94%	0.00%	0.00%	0.00%	4.47%
Enterprise Value to Invested Capital (EV/IC)	2.57	2.87	3.07	2.41	2.74	4.13	3.23	1.71	2.36	4.07	3.17
Enterprise Value to Revenue (EV/Rev)	1.67	2.03	2.22	2.09	2.04	2.21	1.87	1.23	1.48	1.97	1.54
Enterprise Value to EBITDA (EV/EBITDA)	12.29	9.78	11.72	19.84	8.38	13.02	11.04	0.00	0.00	24.64	12.29
Enterprise Value to EBIT (EV/EBIT)	15.63	11.39	13.95	28.24	9.48	15.06	12.44	0.00	0.00	34.40	14.90
Enterprise Value to NOPAT (EV/NOPAT)	24.90	17.75	21.47	25.38	20.95	20.55	16.70	0.00	0.00	47.85	22.41
Enterprise Value to Operating Cash Flow (EV/OCF)	16.07	20.89	16.13	16.26	28.41	16.33	33.97	0.00	9.87	10.48	14.18
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	101.14	42.12	0.00	25.02	15.40	0.00	0.00	10.55	10.84	17.81
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.83	1.66	2.12	5.61	2.28	2.16	2.26	20.11	-9.76	-5.70	-5.89
Long-Term Debt to Equity	1.62	1.40	1.90	5.24	2.11	2.07	2.21	19.13	-9.57	-5.57	-5.73
Financial Leverage	1.34	1.43	1.64	3.13	3.31	2.20	1.95	3.90	-43.28	-6.99	-5.52
Leverage Ratio	3.82	3.86	3.94	5.68	5.62	4.49	4.77	7.84	-64.47	-9.55	-7.50
Compound Leverage Factor	3.09	3.31	2.96	3.33	4.80	3.79	4.35	10.24	-167.86	1.11	-4.71
Debt to Total Capital	64.65%	62.35%	67.92%	84.87%	69.55%	68.40%	69.37%	95.26%	111.41%	121.27%	120.44%
Short-Term Debt to Total Capital	7.40%	9.49%	6.94%	5.58%	5.39%	2.99%	1.75%	4.63%	2.23%	2.86%	3.27%
Long-Term Debt to Total Capital	57.24%	52.86%	60.99%	79.28%	64.15%	65.42%	67.62%	90.64%	109.18%	118.41%	117.17%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.69%	0.98%	0.63%	0.21%	0.19%	0.26%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	34.66%	36.67%	31.45%	14.92%	30.26%	31.34%	30.63%	4.74%	-11.41%	-21.27%	-20.44%
Debt to EBITDA	3.59	2.33	2.80	7.19	2.15	2.17	2.75	-9.23	-31.98	7.84	4.92
Net Debt to EBITDA	3.36	2.08	2.50	6.94	2.12	2.15	2.21	-8.36	-30.46	7.43	4.71
Long-Term Debt to EBITDA	3.18	1.98	2.52	6.71	1.98	2.08	2.68	-8.78	-31.34	7.66	4.78
Debt to NOPAT	7.27	4.24	5.13	9.19	5.37	3.43	4.15	-9.78	-21.38	15.24	8.97
Net Debt to NOPAT	6.82	3.78	4.58	8.87	5.31	3.39	3.34	-8.85	-20.36	14.44	8.58
Long-Term Debt to NOPAT	6.43	3.59	4.61	8.59	4.95	3.28	4.05	-9.30	-20.95	14.88	8.73
Altman Z-Score	2.80	3.22	3.43	2.42	3.79	4.12	3.39	1.51	1.74	2.61	2.54
Noncontrolling Interest Sharing Ratio	2.16%	2.30%	2.29%	1.75%	0.88%	0.72%	0.33%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.81	1.46	1.62	1.45	1.68	1.28	1.77	2.06	1.81	1.31	1.27
Quick Ratio	0.62	0.47	0.75	0.56	0.53	0.54	0.64	0.48	0.43	0.33	0.30
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-119	50	139	-175	258	592	-97	-285	497	645	296
Operating Cash Flow to CapEx	439.32%	436.49%	568.39%	542.79%	562.78%	0.00%	254.45%	-256.97%	588.04%	818.01%	381.21%
Free Cash Flow to Firm to Interest Expense	-2.44	0.70	1.83	-2.03	2.53	6.25	-1.22	-2.41	2.79	4.06	2.29
Operating Cash Flow to Interest Expense	5.06	3.40	4.77	3.96	2.23	5.89	3.44	-1.09	2.98	4.20	2.88
Operating Cash Flow Less CapEx to Interest Expense	3.91	2.62	3.93	3.23	1.83	6.45	2.09	-1.52	2.47	3.69	2.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.03	0.95	0.96	0.92	1.04	1.29	1.20	0.86	0.92	1.13	1.22
Accounts Receivable Turnover	12.42	17.61	16.27	12.57	14.03	11.83	10.28	9.10	10.40	14.77	18.77
Inventory Turnover	4.00	4.06	4.16	4.05	4.18	4.79	3.95	2.47	2.60	3.68	4.01
Fixed Asset Turnover	5.38	5.64	5.79	5.33	5.86	0.00	0.00	6.39	5.84	5.83	5.50
Accounts Payable Turnover	8.08	9.90	11.74	11.85	11.72	9.20	6.91	5.91	8.34	10.28	9.79
Days Sales Outstanding (DSO)	29.38	20.73	22.43	29.03	26.02	30.86	35.51	40.10	35.10	24.71	19.45
Days Inventory Outstanding (DIO)	91.34	89.84	87.69	90.18	87.28	76.17	92.33	147.74	140.24	99.13	90.93
Days Payable Outstanding (DPO)	45.20	36.85	31.08	30.80	31.15	39.66	52.83	61.73	43.75	35.52	37.28
Cash Conversion Cycle (CCC)	75.52	73.71	79.04	88.42	82.14	67.37	75.01	126.12	131.58	88.32	73.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,541	1,777	1,911	2,306	2,356	2,208	2,857	2,838	2,219	1,719	1,659
Invested Capital Turnover	1.69	1.51	1.43	1.26	1.35	1.81	1.94	1.38	1.40	1.80	2.02
Increase / (Decrease) in Invested Capital	279	237	134	395	50	-148	649	-19	-619	-499	-61
Enterprise Value (EV)	3,967	5,096	5,859	5,568	6,444	9,114	9,224	4,846	5,242	6,994	5,263
Market Capitalization	2,869	3,991	4,597	3,617	4,807	7,603	7,380	2,156	2,756	4,884	3,247
Book Value per Share	$10.13	$11.80	$11.11	$6.40	$12.95	$12.50	$18.16	$2.67	($4.76)	($6.87)	($6.19)
Tangible Book Value per Share	($5.19)	($5.72)	($9.27)	($18.86)	($9.51)	($9.43)	($5.40)	($12.39)	($16.88)	($18.54)	($17.37)
Total Capital	1,791	1,950	2,063	2,376	2,375	2,224	3,308	3,118	2,342	1,836	1,749
Total Debt	1,158	1,216	1,401	2,016	1,652	1,522	2,295	2,971	2,610	2,227	2,106
Total Long-Term Debt	1,025	1,031	1,258	1,884	1,524	1,455	2,237	2,826	2,557	2,174	2,049
Net Debt	1,086	1,086	1,250	1,946	1,633	1,505	1,843	2,690	2,486	2,110	2,016
Capital Expenditures (CapEx)	56	56	64	63	40	-53	107	50	90	82	97
Debt-free, Cash-free Net Working Capital (DFCFNWC)	562	482	360	372	531	316	697	1,076	645	211	221
Debt-free Net Working Capital (DFNWC)	633	511	480	406	549	333	941	1,162	676	283	258
Net Working Capital (NWC)	501	326	337	273	421	266	884	1,018	624	230	201
Net Nonoperating Expense (NNE)	0.64	-28	54	156	-153	55	39	134	258	181	90
Net Nonoperating Obligations (NNO)	908	1,043	1,250	1,946	1,633	1,505	1,843	2,690	2,486	2,110	2,016
Total Depreciation and Amortization (D&A)	69	74	80	83	89	95	94	105	93	81	75
Debt-free, Cash-free Net Working Capital to Revenue	23.69%	19.24%	13.62%	13.96%	16.81%	7.65%	14.16%	27.41%	18.15%	5.94%	6.48%
Debt-free Net Working Capital to Revenue	26.70%	20.38%	18.18%	15.23%	17.40%	8.05%	19.11%	29.62%	19.05%	7.96%	7.55%
Net Working Capital to Revenue	21.11%	13.00%	12.76%	10.25%	13.35%	6.44%	17.94%	25.94%	17.57%	6.48%	5.88%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.62	$5.16	$3.68	$1.13	$8.30	$6.96	$9.20	($7.88)	($6.79)	($0.61)	$2.52
Adjusted Weighted Average Basic Shares Outstanding	61.51M	60.09M	57.53M	55.33M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M	58.00M
Adjusted Diluted Earnings per Share	$2.57	$5.09	$3.63	$1.12	$8.18	$6.81	$8.96	($7.88)	($6.79)	($0.61)	$2.47
Adjusted Weighted Average Diluted Shares Outstanding	61.51M	60.09M	57.53M	55.33M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M	58.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	61.51M	60.09M	57.53M	55.33M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M	58.00M
Normalized Net Operating Profit after Tax (NOPAT)	204	254	276	232	313	444	556	181	74	190	276
Normalized NOPAT Margin	8.58%	10.14%	10.45%	8.70%	9.92%	10.75%	11.28%	4.62%	2.09%	5.35%	8.10%
Pre Tax Income Margin	8.65%	15.31%	11.92%	4.34%	18.43%	12.36%	13.75%	-14.22%	-12.76%	-0.66%	6.50%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.20	6.24	5.52	2.28	6.68	6.39	9.40	-3.62	-0.98	1.28	2.74
NOPAT to Interest Expense	3.27	4.00	3.59	2.54	3.02	4.68	7.00	-2.57	-0.69	0.92	1.82
EBIT Less CapEx to Interest Expense	4.05	5.46	4.68	1.55	6.28	6.95	8.05	-4.04	-1.48	0.77	1.99
NOPAT Less CapEx to Interest Expense	2.11	3.22	2.75	1.81	2.63	5.24	5.65	-3.00	-1.19	0.41	1.07
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	70.13%	37.04%	58.68%	188.38%	27.05%	105.82%	27.85%	-37.99%	-39.23%	-433.52%	106.27%
Augmented Payout Ratio	79.46%	80.69%	175.32%	813.81%	27.73%	119.51%	53.04%	-96.94%	-41.67%	-448.14%	118.94%

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/30/2024	12/28/2024	3/29/2025	6/28/2025	9/30/2025	12/27/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.68%	-24.13%	-22.07%	-0.40%	7.46%	10.73%	1.56%	-6.84%	-1.18%	-6.61%	-3.33%
EBITDA Growth	118.66%	-100.97%	-92.00%	27.69%	120.08%	49.89%	-15.97%	24.54%	6.02%	32.61%	83.69%
EBIT Growth	113.71%	-87.06%	-21.64%	31.89%	158.52%	47.74%	-6.95%	26.76%	7.55%	30.30%	51.17%
NOPAT Growth	116.50%	-85.76%	-13.16%	29.48%	122.35%	48.07%	-7.82%	27.79%	7.06%	30.54%	52.40%
Net Income Growth	109.84%	-112.86%	-24.42%	43.97%	202.29%	47.92%	13.66%	38.10%	12.87%	37.75%	-79.86%
EPS Growth	109.61%	-113.04%	-21.37%	41.24%	196.10%	49.46%	14.79%	35.77%	11.40%	38.72%	-78.51%
Operating Cash Flow Growth	21.51%	-2.78%	20.48%	324.83%	4.51%	-77.86%	-29.75%	-38.17%	-22.72%	46.92%	16.82%
Free Cash Flow Firm Growth	171.41%	338.00%	47.83%	6.17%	60.52%	6.16%	-49.85%	-63.71%	-82.13%	-112.75%	-98.20%
Invested Capital Growth	-18.29%	-21.81%	-22.15%	-31.13%	-34.58%	-22.50%	-15.02%	-9.03%	-2.86%	-3.53%	-1.26%
Revenue Q/Q Growth	-26.95%	-66.52%	9.59%	271.69%	-21.19%	-65.50%	0.51%	240.93%	-16.40%	-67.40%	-8.49%
EBITDA Q/Q Growth	-56.30%	-495.68%	92.69%	1,110.42%	-24.67%	-190.10%	83.09%	1,185.03%	-35.87%	-157.27%	96.54%
EBIT Q/Q Growth	-62.56%	-641.22%	88.25%	653.99%	-26.62%	-209.41%	75.95%	756.60%	-37.74%	-170.91%	84.83%
NOPAT Q/Q Growth	-56.86%	-548.37%	88.63%	688.87%	-25.92%	-204.73%	76.40%	797.93%	-37.94%	-167.95%	85.48%
Net Income Q/Q Growth	-60.05%	-1,172.08%	82.82%	295.65%	-16.13%	-284.71%	71.52%	412.95%	-31.45%	-201.88%	17.71%
EPS Q/Q Growth	-60.31%	-1,181.82%	82.95%	292.96%	-16.79%	-284.65%	71.26%	407.44%	-31.72%	-201.57%	16.28%
Operating Cash Flow Q/Q Growth	515.82%	-4.85%	-164.11%	188.64%	93.29%	-79.85%	-475.78%	142.24%	141.57%	-61.69%	-312.75%
Free Cash Flow Firm Q/Q Growth	-39.49%	-55.36%	110.17%	87.02%	-8.52%	-70.48%	-0.73%	35.34%	-54.94%	-121.06%	121.50%
Invested Capital Q/Q Growth	-14.84%	-25.81%	14.35%	-4.67%	-19.11%	-12.11%	25.38%	2.06%	-13.63%	-12.72%	17.55%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	18.41%	-15.22%	15.16%	30.40%	29.45%	-7.11%	22.74%	38.56%	31.82%	6.07%	25.03%
EBITDA Margin	8.90%	-105.23%	-7.02%	19.08%	18.23%	-47.62%	-8.01%	25.50%	19.56%	-34.37%	-1.30%
Operating Margin	6.91%	-111.11%	-11.53%	17.84%	16.64%	-52.11%	-12.24%	24.26%	18.10%	-38.76%	-6.15%
EBIT Margin	6.87%	-111.13%	-11.92%	17.76%	16.54%	-52.45%	-12.55%	24.17%	18.00%	-39.14%	-6.49%
Profit (Net Income) Margin	3.91%	-125.10%	-19.62%	10.33%	10.99%	-58.84%	-16.67%	15.31%	12.55%	-39.22%	-35.27%
Tax Burden Percent	84.04%	83.54%	70.49%	71.66%	72.19%	78.16%	72.47%	72.28%	71.92%	79.70%	197.47%
Interest Burden Percent	67.62%	134.74%	233.54%	81.14%	92.05%	143.54%	183.37%	87.62%	96.96%	125.73%	275.22%
Effective Tax Rate	15.96%	0.00%	0.00%	28.34%	27.81%	0.00%	0.00%	27.72%	28.08%	0.00%	0.00%
Return on Invested Capital (ROIC)	6.41%	-109.25%	-9.56%	14.78%	17.06%	-65.82%	-12.99%	26.23%	23.22%	-54.82%	-7.46%
ROIC Less NNEP Spread (ROIC-NNEP)	5.71%	-116.10%	-11.11%	13.54%	16.56%	-69.85%	-14.21%	25.00%	22.96%	-57.09%	-11.94%
Return on Net Nonoperating Assets (RNNOA)	63.00%	5,024.44%	208.72%	-721.69%	-7,204.46%	487.96%	91.30%	-238.46%	-302.19%	314.88%	59.74%
Return on Equity (ROE)	69.41%	4,915.18%	199.16%	-706.91%	-7,187.39%	422.15%	78.31%	-212.23%	-278.97%	260.06%	52.28%
Cash Return on Invested Capital (CROIC)	20.50%	19.66%	20.57%	34.18%	42.05%	32.78%	22.36%	15.18%	10.95%	17.50%	14.05%
Operating Return on Assets (OROA)	5.34%	-102.37%	-9.92%	13.67%	14.62%	-59.29%	-12.97%	22.38%	18.82%	-47.60%	-7.12%
Return on Assets (ROA)	3.04%	-115.24%	-16.33%	7.95%	9.72%	-66.51%	-17.24%	14.17%	13.12%	-47.69%	-38.67%
Return on Common Equity (ROCE)	69.41%	4,915.18%	199.16%	-706.91%	-7,187.39%	422.15%	78.31%	-212.23%	-278.97%	260.06%	52.28%
Return on Equity Simple (ROE_SIMPLE)	-97.70%	0.00%	102.72%	138.62%	177.43%	0.00%	4.98%	-12.44%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	65	-291	-33	195	144	-151	-36	249	155	-105	-15
NOPAT Margin	5.81%	-77.78%	-8.07%	12.78%	12.02%	-36.48%	-8.57%	17.53%	13.02%	-27.13%	-4.31%
Net Nonoperating Expense Percent (NNEP)	0.70%	6.85%	1.55%	1.24%	0.50%	4.04%	1.22%	1.23%	0.27%	2.27%	4.48%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-1.26%	-	-	-	-1.61%	11.04%	7.67%	-6.01%	-0.75%
Cost of Revenue to Revenue	81.59%	115.22%	84.84%	69.60%	70.55%	107.11%	77.26%	61.44%	68.18%	93.93%	74.97%
SG&A Expenses to Revenue	11.49%	28.84%	27.97%	11.72%	12.30%	28.36%	29.94%	13.25%	12.91%	35.35%	29.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.50%	95.89%	26.68%	12.56%	12.81%	45.00%	34.98%	14.30%	13.72%	44.82%	31.18%
Earnings before Interest and Taxes (EBIT)	77	-416	-49	271	199	-218	-52	343	214	-152	-23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	100	-394	-29	291	219	-198	-33	362	232	-133	-4.60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	24.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.91	0.78	1.00	1.22	1.05	1.37	1.07	0.91	1.10	0.95	0.99
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	87.18	71.45	22.36	37.45
Dividend Yield	4.41%	5.38%	4.31%	3.57%	4.06%	3.07%	4.00%	4.82%	4.02%	4.69%	4.56%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.15%	1.40%	4.47%	2.67%
Enterprise Value to Invested Capital (EV/IC)	2.08	2.36	2.51	2.83	2.96	4.07	2.98	2.56	3.09	3.17	2.99
Enterprise Value to Revenue (EV/Rev)	1.69	1.48	1.85	2.00	1.65	1.97	1.81	1.63	1.70	1.54	1.72
Enterprise Value to EBITDA (EV/EBITDA)	53.36	0.00	0.00	0.00	66.41	24.64	23.01	16.08	16.12	12.29	12.92
Enterprise Value to EBIT (EV/EBIT)	316.92	0.00	0.00	0.00	1,260.42	34.40	32.15	20.70	20.41	14.90	15.47
Enterprise Value to NOPAT (EV/NOPAT)	501.34	0.00	0.00	0.00	941.23	47.85	44.76	42.63	37.79	22.41	23.27
Enterprise Value to Operating Cash Flow (EV/OCF)	11.37	9.87	10.27	6.47	5.35	10.48	11.37	12.55	18.58	14.18	13.09
Enterprise Value to Free Cash Flow (EV/FCFF)	9.11	10.55	10.68	6.77	5.57	10.84	12.25	16.08	27.77	17.81	21.18
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	22.85	-9.76	-7.85	-11.23	-17.03	-5.70	-5.61	-8.78	-12.80	-5.89	-5.05
Long-Term Debt to Equity	19.50	-9.57	-7.70	-11.00	-16.66	-5.57	-5.50	-8.59	-12.50	-5.73	-4.50
Financial Leverage	11.03	-43.28	-18.78	-53.29	-434.93	-6.99	-6.43	-9.54	-13.16	-5.52	-5.00
Leverage Ratio	17.09	-64.47	-25.31	-78.59	-696.82	-9.55	-7.96	-13.79	-20.75	-7.50	-6.33
Compound Leverage Factor	11.56	-86.87	-59.12	-63.77	-641.44	-13.71	-14.60	-12.08	-20.12	-9.43	-17.42
Debt to Total Capital	95.81%	111.41%	114.61%	109.77%	106.24%	121.27%	121.68%	112.85%	108.47%	120.44%	124.69%
Short-Term Debt to Total Capital	14.02%	2.23%	2.07%	2.25%	2.26%	2.86%	2.47%	2.42%	2.58%	3.27%	13.72%
Long-Term Debt to Total Capital	81.78%	109.18%	112.54%	107.52%	103.98%	118.41%	119.21%	110.43%	105.89%	117.17%	110.96%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	4.19%	-11.41%	-14.61%	-9.77%	-6.24%	-21.27%	-21.68%	-12.85%	-8.47%	-20.44%	-24.69%
Debt to EBITDA	26.46	-31.98	-31.69	-87.25	28.51	7.84	9.64	7.26	6.01	4.92	5.60
Net Debt to EBITDA	24.53	-30.46	-30.63	-82.64	24.08	7.43	9.44	7.10	5.69	4.71	5.49
Long-Term Debt to EBITDA	22.58	-31.34	-31.12	-85.46	27.91	7.66	9.44	7.11	5.87	4.78	4.98
Debt to NOPAT	248.55	-21.38	-24.01	-35.32	404.11	15.24	18.75	19.26	14.10	8.97	10.08
Net Debt to NOPAT	230.48	-20.36	-23.21	-33.45	341.33	14.44	18.36	18.83	13.34	8.58	9.88
Long-Term Debt to NOPAT	212.17	-20.95	-23.58	-34.59	395.52	14.88	18.37	18.85	13.76	8.73	8.97
Altman Z-Score	1.91	1.51	1.82	2.15	2.27	2.13	2.01	2.18	2.45	1.93	1.86
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.69	1.81	2.20	1.83	1.80	1.31	1.88	1.71	1.61	1.27	1.35
Quick Ratio	0.89	0.43	0.39	0.89	0.92	0.33	0.33	0.81	0.78	0.30	0.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	734	328	689	1,288	1,178	348	345	467	211	-44	9.54
Operating Cash Flow to CapEx	2,557.27%	2,817.37%	-905.54%	1,866.26%	4,454.55%	713.86%	-1,519.80%	2,266.27%	2,688.76%	405.83%	-1,852.00%
Free Cash Flow to Firm to Interest Expense	15.59	8.19	16.09	29.21	30.37	10.51	10.25	12.77	6.62	-1.66	0.35
Operating Cash Flow to Interest Expense	11.94	13.38	-8.02	6.90	15.15	3.58	-13.21	5.14	14.29	6.52	-13.62
Operating Cash Flow Less CapEx to Interest Expense	11.48	12.91	-8.90	6.53	14.81	3.08	-14.08	4.91	13.76	4.91	-14.35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.92	0.83	0.77	0.88	1.13	1.03	0.93	1.05	1.22	1.10
Accounts Receivable Turnover	3.48	10.40	8.83	2.94	4.22	14.77	14.20	4.12	6.38	18.77	18.54
Inventory Turnover	2.64	2.60	2.09	2.82	3.61	3.68	2.57	3.11	4.26	4.01	2.79
Fixed Asset Turnover	6.04	5.84	5.71	5.73	5.91	5.83	5.85	5.71	5.69	5.50	5.71
Accounts Payable Turnover	9.22	8.34	8.04	6.44	7.88	10.28	8.34	5.95	8.47	9.79	8.29
Days Sales Outstanding (DSO)	105.03	35.10	41.33	124.26	86.48	24.71	25.70	88.55	57.20	19.45	19.68
Days Inventory Outstanding (DIO)	138.22	140.24	174.98	129.34	101.22	99.13	141.81	117.21	85.77	90.93	131.01
Days Payable Outstanding (DPO)	39.59	43.75	45.40	56.71	46.31	35.52	43.77	61.39	43.10	37.28	44.01
Cash Conversion Cycle (CCC)	203.66	131.58	170.91	196.89	141.40	88.32	123.74	144.37	99.88	73.10	106.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,990	2,219	2,537	2,419	1,956	1,719	2,156	2,200	1,900	1,659	1,950
Invested Capital Turnover	1.10	1.40	1.19	1.16	1.42	1.80	1.52	1.50	1.78	2.02	1.73
Increase / (Decrease) in Invested Capital	-669	-619	-722	-1,093	-1,034	-499	-381	-218	-56	-61	-25
Enterprise Value (EV)	6,212	5,242	6,363	6,856	5,798	6,994	6,426	5,638	5,865	5,263	5,839
Market Capitalization	3,356	2,756	3,441	4,187	3,695	4,884	3,791	3,147	3,794	3,247	3,360
Book Value per Share	$2.40	($4.76)	($6.80)	($4.43)	($2.57)	($6.87)	($8.35)	($5.05)	($2.96)	($6.19)	($8.63)
Tangible Book Value per Share	($12.13)	($16.88)	($18.74)	($16.29)	($14.35)	($18.54)	($19.83)	($16.46)	($14.28)	($17.37)	($18.90)
Total Capital	3,214	2,342	2,638	2,567	2,343	1,836	2,212	2,258	2,017	1,749	2,028
Total Debt	3,080	2,610	3,024	2,818	2,489	2,227	2,692	2,548	2,188	2,106	2,529
Total Long-Term Debt	2,629	2,557	2,969	2,761	2,436	2,174	2,637	2,493	2,136	2,049	2,250
Net Debt	2,856	2,486	2,922	2,669	2,103	2,110	2,635	2,490	2,071	2,016	2,480
Capital Expenditures (CapEx)	22	19	38	16	13	17	29	8.30	17	43	20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,345	645	961	868	457	211	646	754	486	221	595
Debt-free Net Working Capital (DFNWC)	1,373	676	972	933	737	283	656	771	537	258	603
Net Working Capital (NWC)	922	624	917	875	684	230	602	716	485	201	325
Net Nonoperating Expense (NNE)	21	177	47	37	12	93	34	32	5.54	47	110
Net Nonoperating Obligations (NNO)	2,856	2,486	2,922	2,669	2,103	2,110	2,635	2,490	2,071	2,016	2,450
Total Depreciation and Amortization (D&A)	23	22	20	20	20	20	19	19	19	19	18
Debt-free, Cash-free Net Working Capital to Revenue	36.65%	18.15%	27.99%	25.30%	13.01%	5.94%	18.16%	21.82%	14.12%	6.48%	17.49%
Debt-free Net Working Capital to Revenue	37.40%	19.05%	28.29%	27.20%	20.98%	7.96%	18.44%	22.31%	15.60%	7.55%	17.73%
Net Working Capital to Revenue	25.12%	17.57%	26.70%	25.51%	19.47%	6.48%	16.90%	20.73%	14.09%	5.88%	9.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.78	($8.35)	($1.42)	$2.77	$2.33	($4.29)	($1.21)	$3.78	$2.58	($2.63)	($2.16)
Adjusted Weighted Average Basic Shares Outstanding	56.20M	56.55M	56.70M	56.80M	56.80M	57.41M	57.30M	57.60M	57.70M	58.00M	57.90M
Adjusted Diluted Earnings per Share	$0.77	($8.33)	($1.42)	$2.74	$2.28	($4.21)	($1.21)	$3.72	$2.54	($2.58)	($2.16)
Adjusted Weighted Average Diluted Shares Outstanding	56.60M	56.55M	56.70M	57.40M	58M	57.41M	57.30M	58.40M	58.60M	58.00M	57.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.16M	56.55M	56.69M	56.80M	56.82M	57.41M	57.47M	57.72M	57.74M	58.00M	58.04M
Normalized Net Operating Profit after Tax (NOPAT)	66	-117	-38	196	144	-103	-24	257	156	-81	-14
Normalized NOPAT Margin	5.93%	-31.33%	-9.28%	12.88%	11.97%	-24.90%	-5.79%	18.08%	13.16%	-21.02%	-3.95%
Pre Tax Income Margin	4.65%	-149.75%	-27.83%	14.41%	15.22%	-75.28%	-23.01%	21.18%	17.45%	-49.21%	-17.86%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.63	-10.41	-1.14	6.14	5.12	-6.57	-1.55	9.38	6.72	-5.68	-0.85
NOPAT to Interest Expense	1.38	-7.28	-0.77	4.42	3.72	-4.57	-1.06	6.81	4.86	-3.94	-0.56
EBIT Less CapEx to Interest Expense	1.17	-10.88	-2.03	5.77	4.78	-7.07	-2.42	9.16	6.19	-7.28	-1.58
NOPAT Less CapEx to Interest Expense	0.91	-7.76	-1.66	4.05	3.38	-5.07	-1.93	6.58	4.33	-5.54	-1.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-112.83%	-39.23%	-37.86%	-43.24%	-58.13%	-433.52%	-640.59%	424.10%	289.64%	106.27%	171.01%
Augmented Payout Ratio	-120.05%	-41.67%	-40.79%	-45.49%	-60.06%	-448.14%	-714.23%	475.35%	324.48%	118.94%	183.39%

Financials Breakdown Chart

Key Financial Trends

Cash flow from continuing operating activities has been positive in multiple quarters, including 2025 Q2 (~$188.1M), 2025 Q3 (~$454.4M), and 2025 Q4 (~$174.1M), indicating improving cash generation in the core business.
Net income from continuing operations turned positive in mid-2025 quarters: 2025 Q2 (~$217.5M) and 2025 Q3 (~$149.1M), signaling a period of improved profitability.
Trailing per‑share results showed meaningful earnings in the strong quarter: 2025 Q3 Basic EPS ~$2.58 and Diluted EPS ~$2.54.
Top-line momentum in mid-2025, with 2025 Q2 Operating Revenue of about $1.421B and 2025 Q3 around $1.188B, suggesting a rebound in demand during the year.
Debt financing activity has provided liquidity when needed: 2025 Q2 Issuance of Debt (~$116.8M) and 2026 Q1 Issuance of Debt (~$1.146B) contributed to stronger near-term liquidity.
Seasonality remains a factor, as seen by weaker Q4 results (e.g., 2025 Q4 revenue ~$387.3M) relative to mid-year quarters, indicating quarterly volatility tied to gardening seasons.
The balance sheet carries a substantial leverage load, with long-term debt typically in the $2.0–2.5B range and total liabilities above $3.0B in recent periods, implying meaningful leverage risk.
Shareholders’ equity is repeatedly negative in several quarters (e.g., 2026 Q1 Total Common Equity around -$500.6M; 2025 Q3 around -$170.9M), signaling ongoing equity erosion and potential restructuring considerations.
Profitability has been volatile, with net losses in multiple quarters, including 2026 Q1 net income -$125.0M and 2025 Q4 net income -$151.9M.
Investing activities have represented cash outflows in several periods (e.g., 2025 Q3 PPE purchase of -$16.9M; 2025 Q2 PPE -$8.3M; 2026 Q1 PPE -$20.0M), contributing to cash burn and pressuring cash balances.

05/05/26 06:01 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Scotts Miracle-Gro's Financials

When does Scotts Miracle-Gro's financial year end?

According to the most recent income statement we have on file, Scotts Miracle-Gro's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

How has Scotts Miracle-Gro's net income changed over the last 10 years?

Scotts Miracle-Gro's net income appears to be on a downward trend, with a most recent value of $145.20 million in 2025, falling from $158.70 million in 2015. The previous period was -$34.90 million in 2024. See where experts think Scotts Miracle-Gro is headed by visiting Scotts Miracle-Gro's forecast page.

What is Scotts Miracle-Gro's operating income?

Scotts Miracle-Gro's total operating income in 2025 was $358.60 million, based on the following breakdown:

Total Gross Profit: $1.04 billion
Total Operating Expenses: $685.60 million

How has Scotts Miracle-Gro's revenue changed over the last 10 years?

Over the last 10 years, Scotts Miracle-Gro's total revenue changed from $2.37 billion in 2015 to $3.41 billion in 2025, a change of 43.9%.

How much debt does Scotts Miracle-Gro have?

Scotts Miracle-Gro's total liabilities were at $3.10 billion at the end of 2025, a 5.0% decrease from 2024, and a 63.6% increase since 2015.

How much cash does Scotts Miracle-Gro have?

In the past 10 years, Scotts Miracle-Gro's cash and equivalents has ranged from $16.60 million in 2020 to $244.10 million in 2021, and is currently $32.80 million as of their latest financial filing in 2025.

How has Scotts Miracle-Gro's book value per share changed over the last 10 years?

Over the last 10 years, Scotts Miracle-Gro's book value per share changed from 10.13 in 2015 to -6.19 in 2025, a change of -161.1%.

Related Companies

Financial statements for NYSE:SMG last updated on 2/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Scotts Miracle-Gro (SMG) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Scotts Miracle-Gro's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Scotts Miracle-Gro (SMG) Financials

Annual Income Statements for Scotts Miracle-Gro

Quarterly Income Statements for Scotts Miracle-Gro

Annual Cash Flow Statements for Scotts Miracle-Gro

Quarterly Cash Flow Statements for Scotts Miracle-Gro

Annual Balance Sheets for Scotts Miracle-Gro

Quarterly Balance Sheets for Scotts Miracle-Gro

Annual Metrics And Ratios for Scotts Miracle-Gro

Quarterly Metrics And Ratios for Scotts Miracle-Gro

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Scotts Miracle-Gro's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools